The FDA/CMS Summit 2019 is dedicated to policies, regulatory updates and initiatives impacting biopharma and medical devices.
The FDA/CMS Summit 2019 covers topics such as:
- The state of biosimilars in the US
- Goals, trends, and new drug development
- The implication of a more vocal patient role in drug development
- The economics and impacts of biosimilars on healthcare